Advances in Dermatology and Allergology (Jun 2022)
The "real-world" effectiveness and safety of omalizumab in patients with uncontrolled persistent allergic asthma in Slovakia: a subgroup analysis of the eXpeRience study
Abstract
No abstracts available.Keywords